Search Results - Kim Rand

  • Showing 1 - 11 results of 11
Refine Results
  1. 1

    Quality of life among patients seeking treatment for substance use disorder, as measured with the EQ-5D-3L by Kim Rand, Espen Ajo Arnevik, Espen Walderhaug

    Published in Journal of Patient-Reported Outcomes (2020-11-01)
    Get full text
    Article


  2. 2

    Reduced quality of life, more technical challenges, and less study motivation among paramedic students after one year of the COVID-19 pandemic – a survey study by Kristin Häikiö, Astrid Karina Harring, Rune Kveen, Kim Rand, Trine Møgster Jørgensen

    Published in BMC Medical Education (2023-03-01)
    Get full text
    Article


  3. 3

    Health-related quality of life and QALY loss under COVID-19 lockdown: The case of Spain. by Mathieu F Janssen, Kim Rand, Anabel Estévez-Carrillo, Juan Manuel Ramos-Goñi

    Published in PLoS ONE (2025-01-01)
    Get full text
    Article


  4. 4

    Health-related quality of life and QALY loss under COVID-19 lockdown: The case of Spain by Mathieu F. Janssen, Kim Rand, Anabel Estévez-Carrillo, Juan Manuel Ramos-Goñi

    Published in PLoS ONE (2025-01-01)
    Get full text
    Article


  5. 5

    Elicitation of Norwegian EQ-5D-5L values for hypothetical and experience-based health states based on the EuroQol Valuation Technology (EQ-VT) protocol by Knut Stavem, Tonya Moen Hansen, Ylva Helland, Liv Ariane Augestad, Kim Rand, Andrew Garratt

    Published in BMJ Open (2020-06-01)
    Get full text
    Article


  6. 6

    Response to “Letter to the Editor Regarding ‘Matching-Adjusted Indirect Comparison of the Long-Term Efficacy Maintenance and Adverse Event Rates of Lebrikizumab vs. Dupilumab in Mo... by Kim Rand, Juan Manuel Ramos-Goñi, Bülent Akmaz, Laia Solé-Feu, José-Carlos Armario-Hita

    Published in Dermatology and Therapy (2024-03-01)
    Get full text
    Article


  7. 7

    Matching-Adjusted Indirect Comparison of the Long-Term Efficacy Maintenance and Adverse Event Rates of Lebrikizumab versus Dupilumab in Moderate-to-Severe Atopic Dermatitis by Kim Rand, Juan Manuel Ramos-Goñi, Bülent Akmaz, Laia Solé-Feu, José-Carlos Armario-Hita

    Published in Dermatology and Therapy (2023-10-01)
    Get full text
    Article


  8. 8

    Correction to: Matching-Adjusted Indirect Comparison of the Long-Term Efficacy Maintenance and Adverse Event Rates of Lebrikizumab versus Dupilumab in Moderate-to-Severe Atopic Der... by Kim Rand, Juan Manuel Ramos-Goñi, Bülent Akmaz, Laia Solé-Feu, José-Carlos Armario-Hita

    Published in Dermatology and Therapy (2024-01-01)
    Get full text
    Article


  9. 9

    Fewer ischemic strokes, despite an ageing population: stroke models from observed incidence in Norway 2010–2015 by Kim Rand, Fredrik Andreas Dahl, Joe Viana, Ole Morten Rønning, Kashif Waqar Faiz, Mathias Barra

    Published in BMC Health Services Research (2019-10-01)
    Get full text
    Article


  10. 10

    Prospective assessment of clinical outcomes of transcatheter aortic valve implantation in a cohort of patients based on their risk profile by Eduardo Pinar, Juan García de Lara, José Hurtado, Miguel Robles, Gunnar Leithold, Belén Martí-Sánchez, Paloma González, Kim Rand, Jesús Cuervo

    Get full text
    Article


  11. 11

    Digital thErapy For Improved tiNnitus carE Study (DEFINE): Protocol for a randomised controlled trial. by Matthew E Smith, Dhiraj Sharma, Oliver Rivero-Arias, Kim Rand, Lucy Barrack, Emma Ogburn, Michael Young, Polly Field, Jan Multmeier, Jameel Muzaffar

    Published in PLoS ONE (2024-01-01)
    Get full text
    Article


Search Tools: